IMTX

Immatics N.V.

24
Fundamentals12/ 100
Valuation50/ 100
Upside potential56/ 100
Risk potential25/ 100

IMTX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.

IMTX Fundamentals

MetricStatus
Under pressure
Weak
Weak
Strong

IMTX's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.

IMTX PE Valuation

IMTX has no meaningful PE right now: it lost money over the past year.

IMTX Forward outlook

MetricOutlook
--
Losses growing
Strong decline
--
Limited
Low

Analysts expect IMTX's losses to grow, with revenue declining. However, they disagree widely on these estimates.

IMTX Risk to reward

ScenarioChangePrice
Upside+32%$8.62
Downside-25%$4.90

Calculated from the latest close: $6.52 on Nov 12.

IMTX's one-year upside scenario is somewhat larger than its downside: +32% against −25%.

IMTX Earnings Per Share

Q3 2023: $-1.19Q4 2023: $-1.34Q1 2024: $-1.09Q2 2024: $-0.92Q3 2024: $-0.69Q4 2024: $0.17Q1 2025: $-0.17Q2 2025: $-0.62Q3 2025: $-0.97Q4 2025: $-1.79Q1 2026: $-1.90Q2 2026: $-1.77
Q3 2023: $-1.19Q4 2023: $-1.34Q1 2024: $-1.09Q2 2024: $-0.92Q3 2024: $-0.69Q4 2024: $0.17Q1 2025: $-0.17Q2 2025: $-0.62Q3 2025: $-0.97Q4 2025: $-1.79Q1 2026: $-1.90Q2 2026: $-1.77
QuarterTTM EPSYoY
Q2 2026-$1.77-$1.15
Q1 2026-$1.90-$1.73
Q4 2025-$1.79-1153%
Q3 2025-$0.97-$0.28
Q2 2025-$0.62+$0.30
Q1 2025-$0.17+$0.92
Q4 2024$0.17+$1.51
Q3 2024-$0.69+$0.50

IMTX is still losing money, but far less than before: $1.77 per share over the past year, against $4.09 at its worst in mid-2021.

IMTX Quarterly Revenue

Q3 2023: $7MQ4 2023: $18MQ1 2024: $34MQ2 2024: $21MQ3 2024: $56MQ4 2024: $62MQ1 2025: $21MQ2 2025: $5MQ3 2025: $6MQ4 2025: $22MQ1 2026: $8MQ2 2026: $10M
Q3 2023: $7MQ4 2023: $18MQ1 2024: $34MQ2 2024: $21MQ3 2024: $56MQ4 2024: $62MQ1 2025: $21MQ2 2025: $5MQ3 2025: $6MQ4 2025: $22MQ1 2026: $8MQ2 2026: $10M
QuarterRevenueYoY
Q2 2026$10.2M+93%
Q1 2026$8.5M-59%
Q4 2025$22M-65%
Q3 2025$5.8M-90%
Q2 2025$5.3M-75%
Q1 2025$20.6M-39%
Q4 2024$62.5M+253%
Q3 2024$56.2M+753%

IMTX's revenue is recovering but still below its 2022 peak: $10M last quarter, up 93% from the same quarter a year ago.

IMTX Free Cash Flow

Q3 2023: −$41MQ4 2023: $78MQ1 2024: −$47MQ2 2024: −$40MQ3 2024: −$41MQ4 2024: −$67MQ1 2025: −$41MQ2 2025: −$45MQ3 2025: −$51MQ4 2025: −$65MQ1 2026: −$48MQ2 2026: −$69M
Q3 2023: −$41MQ4 2023: $78MQ1 2024: −$47MQ2 2024: −$40MQ3 2024: −$41MQ4 2024: −$67MQ1 2025: −$41MQ2 2025: −$45MQ3 2025: −$51MQ4 2025: −$65MQ1 2026: −$48MQ2 2026: −$69M
QuarterFree cash flowYoY
Q2 2026-$69M-$23.8M
Q1 2026-$48.3M-$6.9M
Q4 2025-$65.1M+$1.8M
Q3 2025-$50.9M-$10.3M
Q2 2025-$45.1M-$5.1M
Q1 2025-$41.5M+$5.2M
Q4 2024-$66.9M-186%
Q3 2024-$40.6M+$557.7K

IMTX has burned cash in most quarters: −$233M over the past year, against −$194M the year before.

IMTX Total Shares

Q3 2023: 83MQ4 2023: 85MQ1 2024: 106MQ2 2024: 103MQ3 2024: 110MQ4 2024: 107MQ1 2025: 122MQ2 2025: 122MQ3 2025: 122MQ4 2025: 126MQ1 2026: 135MQ2 2026: 137M
Q3 2023: 83MQ4 2023: 85MQ1 2024: 106MQ2 2024: 103MQ3 2024: 110MQ4 2024: 107MQ1 2025: 122MQ2 2025: 122MQ3 2025: 122MQ4 2025: 126MQ1 2026: 135MQ2 2026: 137M
PeriodChange %Net change
Quarterly+1.5%+2M shares
1 year+12%+15.1M shares
3 years+77%+59.4M shares
5 years+117%+73.8M shares
Available history+117%+73.8M shares

IMTX has 137M diluted shares, up 12% from a year ago.

IMTX Net Leverage

Q4 2024: -6.4x
Q4 2024: -6.4x
QuarterNet LeverageStatus
Q4 2024-6.4xNet Cash
Q4 2022-3.6xNet Cash
Q3 2022-7.9xNet Cash
Q2 2022-13.0xNet Cash
Q1 2022-20.1xNet Cash

IMTX has more cash than debt.

IMTX Weekly Momentum

MetricValueStatus
RSI33.4Neutral
Stochastic11.5Oversold

IMTX's weekly RSI is 33 (neutral) and its Stochastic is 12 (oversold).

IMTX PE vs Healthcare Sector

MetricIMTXSector medianRelative
PEN/A26x—

IMTX has no meaningful PE right now: it lost money over the past year.

IMTX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$7.199.3% below
20 week MA$8.4523% below
50 week MA$9.4831% below
100 week MA$7.9118% below
200 week MA$9.1529% below

IMTX is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.

IMTX Yearly ROI

YearStart priceEnd priceROI
2020$10.4$9.99-3.9%
2021$9.99$13.0+30%
2022$13.0$8.51-34%
2023$8.51$10.5+24%
2024$10.5$7.13-32%
2025$7.13$10.2+43%
2026 YTD$10.2$6.52-36%

IMTX has finished lower in three of the last six years. It's down 36% so far in 2026.

Give your agent the market.

Get API key